PRME PRIME MEDICINE
Health Care · Russell 2000
Next earnings: not announced yet
What 16 analyst firms say about PRIME MEDICINE: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
13 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 9 reports on PRME from 6 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 4 left it unchanged.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Chardan Capital lowered its target from $9.00 (set 10 Nov 2025) to $7.00 on 25 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BMO Capital Markets | David Lebowitz | Buy | 18 Aug 2026 | 9.00 USD |
| Chardan Capital Markets | Keay Nakae | Buy | 25 Sep 2026 | 7.00 USD |
| Citigroup | Samantha Semenkow | Buy | 25 Sep 2026 | 4.25 USD |
| Citizens JMP | Silvan C Tuerkcan | Buy | 4 Mar 2026 | 6.00 USD |
| Goldman Sachs | Unnamed analyst | — | 22 Jun 2026 | 6.00 USD |
| Guggenheim | Debjit Chattopadhyay | Buy | 17 May 2026 | 5.00 USD |
| H.C. Wainwright | Arthur He | Buy | 1 Oct 2026 | 8.00 USD |
| Jefferies | Maury Raycroft | Buy | 1 Jul 2026 | 8.00 USD |
| Jonestrading | Soumit Roy | Buy | 8 May 2026 | 5.00 USD |
| Lifesci Capital | Thibaut R Pardo-Garcia | Buy | 18 Jun 2026 | 6.00 USD |
| New Street Research | Unnamed analyst | — | 29 Jun 2026 | 8.00 USD |
| Oppenheimer | Kostas Biliouris | Buy | 12 Mar 2026 | 11.00 USD |
| TD Cowen | Joseph Thome | Buy | 8 Jul 2026 | — |
| Wedbush | David M Nierengarten | Buy | 6 Aug 2026 | 8.00 USD |
| Weiss Ratings | Unnamed analyst | — | 31 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.